BG102182A - The use of ipriflavon for reducing the number of cd8+ cells - Google Patents
The use of ipriflavon for reducing the number of cd8+ cellsInfo
- Publication number
- BG102182A BG102182A BG102182A BG10218298A BG102182A BG 102182 A BG102182 A BG 102182A BG 102182 A BG102182 A BG 102182A BG 10218298 A BG10218298 A BG 10218298A BG 102182 A BG102182 A BG 102182A
- Authority
- BG
- Bulgaria
- Prior art keywords
- ipriflavon
- cells
- reducing
- selectivesuppression
- isopropoxyisophalon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a pharmaceutical compositionapplicable in human and veterinary medicine for selectivesuppression of the CD8+ lymphocytes. The composition is preparedby known methods and contains 7-isopropoxyisophalon as activeingredient and suitable inert, solid or liquid carriers,optionally the usual therapeutical additives and auxialiarycompositions.4 claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU9502198A HU9502198D0 (en) | 1995-07-21 | 1995-07-21 | Novel indication |
PCT/HU1996/000038 WO1997003664A1 (en) | 1995-07-21 | 1996-07-16 | Use of ipriflavone to reduce the number of cd8+ cells |
Publications (1)
Publication Number | Publication Date |
---|---|
BG102182A true BG102182A (en) | 1998-08-31 |
Family
ID=10987063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102182A BG102182A (en) | 1995-07-21 | 1998-01-14 | The use of ipriflavon for reducing the number of cd8+ cells |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0841915A1 (en) |
JP (1) | JP2001503371A (en) |
KR (1) | KR19990028933A (en) |
CN (1) | CN1191483A (en) |
AR (1) | AR002905A1 (en) |
AU (1) | AU6367096A (en) |
BG (1) | BG102182A (en) |
BR (1) | BR9610187A (en) |
CA (1) | CA2227421A1 (en) |
CZ (1) | CZ2798A3 (en) |
EA (1) | EA199800146A1 (en) |
EE (1) | EE9800020A (en) |
HR (1) | HRP960345A2 (en) |
HU (1) | HU9502198D0 (en) |
IL (1) | IL122751A0 (en) |
MX (1) | MX9800603A (en) |
NO (1) | NO980127D0 (en) |
PL (1) | PL324460A1 (en) |
SK (1) | SK3298A3 (en) |
WO (1) | WO1997003664A1 (en) |
YU (1) | YU42796A (en) |
ZA (1) | ZA966079B (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1241079B (en) * | 1990-03-23 | 1993-12-29 | Chiesi Farma Spa | PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCEDURE FOR THEIR PREPARATION AND RELATED THERAPEUTIC USE |
HU212932B (en) * | 1993-08-02 | 1996-12-30 | Chinoin Gyogyszer Es Vegyeszet | Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition |
-
1995
- 1995-07-21 HU HU9502198A patent/HU9502198D0/en unknown
-
1996
- 1996-07-16 EA EA199800146A patent/EA199800146A1/en unknown
- 1996-07-16 CN CN96195722A patent/CN1191483A/en active Pending
- 1996-07-16 IL IL12275196A patent/IL122751A0/en unknown
- 1996-07-16 CZ CZ9827A patent/CZ2798A3/en unknown
- 1996-07-16 KR KR1019980700235A patent/KR19990028933A/en not_active Application Discontinuation
- 1996-07-16 CA CA002227421A patent/CA2227421A1/en not_active Abandoned
- 1996-07-16 MX MX9800603A patent/MX9800603A/en unknown
- 1996-07-16 JP JP50646497A patent/JP2001503371A/en active Pending
- 1996-07-16 PL PL96324460A patent/PL324460A1/en unknown
- 1996-07-16 EE EE9800020A patent/EE9800020A/en unknown
- 1996-07-16 AU AU63670/96A patent/AU6367096A/en not_active Abandoned
- 1996-07-16 BR BR9610187A patent/BR9610187A/en not_active Application Discontinuation
- 1996-07-16 EP EP96923004A patent/EP0841915A1/en not_active Withdrawn
- 1996-07-16 WO PCT/HU1996/000038 patent/WO1997003664A1/en not_active Application Discontinuation
- 1996-07-16 SK SK32-98A patent/SK3298A3/en unknown
- 1996-07-17 ZA ZA9606079A patent/ZA966079B/en unknown
- 1996-07-18 HR HRP9502198A patent/HRP960345A2/en not_active Application Discontinuation
- 1996-07-19 YU YU42796A patent/YU42796A/en unknown
- 1996-07-22 AR ARP960103677A patent/AR002905A1/en unknown
-
1998
- 1998-01-12 NO NO980127A patent/NO980127D0/en unknown
- 1998-01-14 BG BG102182A patent/BG102182A/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR002905A1 (en) | 1998-04-29 |
EE9800020A (en) | 1998-08-17 |
SK3298A3 (en) | 1998-07-08 |
KR19990028933A (en) | 1999-04-15 |
AU6367096A (en) | 1997-02-18 |
EP0841915A1 (en) | 1998-05-20 |
CZ2798A3 (en) | 1998-06-17 |
CA2227421A1 (en) | 1997-02-06 |
MX9800603A (en) | 1998-04-30 |
IL122751A0 (en) | 1998-08-16 |
NO980127L (en) | 1998-01-12 |
JP2001503371A (en) | 2001-03-13 |
HU9502198D0 (en) | 1995-09-28 |
PL324460A1 (en) | 1998-05-25 |
ZA966079B (en) | 1998-01-19 |
EA199800146A1 (en) | 1998-08-27 |
BR9610187A (en) | 1998-07-28 |
YU42796A (en) | 1999-03-04 |
WO1997003664A1 (en) | 1997-02-06 |
NO980127D0 (en) | 1998-01-12 |
HRP960345A2 (en) | 1998-02-28 |
CN1191483A (en) | 1998-08-26 |
WO1997003664A8 (en) | 1999-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL84315A0 (en) | Hydrogenated phenylbenzopyrans,their preparation and pharmaceutical compositions containing them | |
EP0612248A4 (en) | Combination chemotherapy. | |
UA37244C2 (en) | Method for treating or preventing clinical disorders curable with progesterone in female patients | |
IL76932A0 (en) | Pharmaceutical compositions containing dihydrocodeine and ibuprofen | |
AU6628496A (en) | Polyether block copolymer micellar compositions for targeting biological agents | |
CA2068324A1 (en) | Metal-peptide compositions and methods for stimulating hair growth | |
MY115662A (en) | Novel compounds with analgesic effect | |
ITMI922953A1 (en) | DOUBLE BIOLOGICAL ACTIVITY OF NO SYNTHASIS AND CYCLOOXYGENES PROCEDURE FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITIONS THAT CONTAIN THEM. | |
ZA874635B (en) | Novel anti-inflammatory agents,pharmaceutical compositions and methods for reducing inflammation | |
AU7554087A (en) | Pharmaceutical composition with analgesic activity | |
EG18379A (en) | Novel pharmacological compounds | |
EP1535929A3 (en) | Megakaryocyte stimulating factors | |
MC1915A1 (en) | Processes for the preparation of 2 ', 3'-dideoxynucleosides and pharmaceutical formulations containing them | |
EP0663835A1 (en) | Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy. | |
IL81833A0 (en) | Renin inhibitors,their preparation and pharmaceutical compositions containing them | |
NZ230155A (en) | N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions | |
BE902796A (en) | ESTER OF ACETYL CARNITINE, ITS PREPARATION AND ITS USE. | |
IL83412A (en) | 5',5'-disubstituted 2',5'-dideoxyuridines and 2',5'-dideoxycytidines,their preparation and pharmaceutical compositions containing them | |
BG102182A (en) | The use of ipriflavon for reducing the number of cd8+ cells | |
AU7439996A (en) | Novel uses of mammalian ctla-8 and related reagents | |
AU2798689A (en) | Oral dosage units for pharmaceuticals and their use and preparation | |
ES8704903A1 (en) | 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepine-N-oxide and medical compositions using it. | |
EP0371733A3 (en) | Dopamine-beta-hydroxylase inhibitors | |
IL80733A0 (en) | 2,2'-bi-1h-imidazoles and pharmaceutical compositions containing same | |
AU576473B2 (en) | Spiro(2h-1,4-benzodioxepin-3(5h)4'-piperidine and 3'- pyrrolidino) compounds |